Morphea

• CLINICAL_TRIALS research · 2026-01-23
  Clinical Trial Update: Patient Reported Outcomes With UVA-1 Therapy for Treatment of Sclerosing Skin Diseases [NA]

  This entry reports on a clinical trial evaluating patient-reported outcomes of UVA-1 phototherapy for treating sclerosing skin diseases, inc…

• CLINICAL_TRIALS research · 2025-04-02
  Clinical Trial Update: Morphea in Adults and Children (MAC) Cohort Study: A Morphea Registry and DNA Repository

  The MAC Cohort Study is a morphea registry and DNA repository sponsored by UT Southwestern Medical Center. It is currently recruiting to col…

• CLINICAL_TRIALS research · 2025-01-30
  Clinical Trial Update: Study on the Treatment With Water-filtered Infrared-A (wIRA) Radiation in Patients With Morphea and Sclerotic Graft-versus-host Disease [NA]

  Clinical trial update indicates that a study evaluating water-filtered infrared-A (wIRA) radiation for Morphea and sclerotic graft-versus-ho…

• CLINICAL_TRIALS trial_result · 2022-06-24
  Clinical Trial Update: A Study of FCX-013 Plus Veledimex for the Treatment of Moderate to Severe Localized Scleroderma (Morphea) [Phase 1, Phase 2]

  A clinical trial evaluating FCX-013 plus Veledimex in moderate to severe localized scleroderma (morphea) was terminated; results were posted…

• CLINICAL_TRIALS trial_result · 2021-04-01
  Clinical Trial Update: Pilot Study Evaluating the Efficacy of a Topical PDE4 Inhibitor for Morphea [Phase 2]

  A Phase 2 pilot study assessing topical PDE4 inhibitor for morphea has completed with results posted.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2018-09-13
  Clinical Trial Update: Molecular Effects of Topical Calcipotriene on Morphea [EARLY_Phase 1]

  Early-phase trial investigating molecular effects of topical calcipotriene on morphea (localized scleroderma) has been terminated with resul…